Once a futuristic concept, CRISPR gene editing is now making its mark in real-world medicine. From curing rare genetic disorders to engineering immune cells to fight cancer, CRISPR is stepping out of the lab and into the hospital.
Landmark Success:
In 2023, the first CRISPR-based therapy for sickle cell disease received regulatory approval in the UK and USA. This therapy edits a patient’s own stem cells to produce healthy red blood cells—offering a potential cure rather than lifelong management.
Cancer Trials:
CAR-T cells enhanced using CRISPR are being tested in clinical trials for leukemia and solid tumors, showing promising results with fewer off-target effects.
Beyond Genetics:
New trials are exploring CRISPR in infectious diseases (like HIV), eye disorders, and even cardiovascular diseases by targeting genetic risk factors.
Would you consider a CRISPR-based treatment if it were offered to you or a loved one? What excites or worries you about this technology?